A Non-randomised, Open Feasibility Pilot for the 'REpurposing BOtulinum Toxin in Treatment of Obesity in Adolescents' (ReBOO) Trial
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 09 Mar 2018
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Acronyms ReBOO
- 01 Mar 2018 Planned End Date changed from 31 Dec 2019 to 1 Apr 2019.
- 01 Mar 2018 Planned primary completion date changed from 31 Dec 2019 to 1 Apr 2018.
- 30 Mar 2017 Status changed from recruiting to active, no longer recruiting.